Envestry Sign Up Information

GlobaTalent gives fans the opportunity to invest in top prospect sports athletes and organisations from around the globe. Already in revenue, GlobaTalent is seeking ?400k in investment and is more than 50% funded.

Already working with tennis-great David Vega and Madrid''s Zentro basketball team, GlobaTalent recently signed a partnership with Jacques Villeneuve''s FEED Racing Drivers'' Academy, which aims to unveil young talent and create the future champions of motorsport.

Art Analysis & Research, the leading scientific art testing company, is pleased to report a positive EBITDA of $175k with a net income of $99k for the first 11 months of the fiscal year. AA&R has put its Series A raise on hold due to COVID-19 and would like to offer Envestors Private Investment Club members a convertible note of up to ?100k in ?10 increments with a rolling close. The terms of the offer include 8% interest and a 1.3 GBP:USD conversion rate with a 20% share price discount on the Series A investment round. The note will close on Friday 10th April, 2020.

Fintech Butterwire has published ''The Big Short Vol'', a comprehensive analysis on the market to help the industry navigate the current environment.

This research emphasises the significance of top down "macro" analysis as part of the active equity investment process and highlights how Butterwire''s approach to this was signalling concern as early as December (from both a macro and stock specific perspective) with the level of concern growing all the way through Q1. This is another example of how tightly integrating investment disciplines - macro, fundamental, quant and trend-following - into the investment methodology that is designed into Butterwire brings enormous?value to stock investors.

Read it for yourself?here.

Itasca Wines announces that, due to Covid 19 restrictions, it is postponing the event planned for 9th April 2020 at Caviste in Hook, Hampshire.

Meanwhile, production of their wines and the progression of their business plan have not been affected by the spread of the virus or the measures put in place by the Government to halt its spread. The team are happy to speak to any prospective investors over the phone or via video call. ?Please get in touch with Sonal Shah? to arrange.?

Zone V makes the latest smartphones and smart devices easier to use for older people and for people of any age with poor?eyesight, hearing or dexterity.

This helps them to stay in touch, use services and be entertained. During the current period of isolation this has become an even greater need for many people across the globe.

Zone V is currently working on plans to make its software widely available and we expect to be in a position to communicate the details of this shortly.

Living With is a health technology company with a patient management app platform that is aiming to change?how easily doctors and hospitals can access digital tools to treat patients remotely, while providing high value data to medical device and drug companies. The company owns Squeezy, the UK''s top paid medical app and with 9 products in 17 NHS Trusts, a contract with one of the world''s largest medical device companies and other deals in progress, is well on the way towards a 5-year turnover of ?30m. Living With has offered the platform to the NHS for free for six months as part of the fight against COVID-19; this should have an immediate impact on patients and constrained clinical resources during this difficult time.

Doc2UK is a specialist UK medical recruitment and candidate support platform, which has been designed to help overseas doctors navigate the system to find permanent positions within the NHS as quickly and painlessly as possible. The current talent pool offered by Doc2UK comes from India, however the team plans to expand to medical professionals in other parts of Asia. The company was founded by medical doctor Naveen Keerthi, who had first-hand experience of moving to the UK from India; his team consists of NHS professionals, who provide the company with over 50 years of combined NHS experience and all of whom traversed the same journey as their candidates. Doc2UK is a part of the NHS England's Clinical Entrepreneur Programme.